Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linperlisib in Relapsed/Refractory Follicular Lymphoma
NCT04370405Phase 2Unknown
- Sponsor
- Yingli Pharma
- Start
- Apr 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linperlisib in follicular lymphoma (FL), sponsored by Yingli Pharma. Status: unknown.
02
Drugs
linperlisib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT04370405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04370405.